WM
70
2
KLAC
42
2
APH
64
3
ISRG
74
-2
QRVO
34
-2
PWR
60
-6
EFX
38
-2
ES
63
5
PSA
48
2
KSS
49
-6
BAX
45
-2
MMM
30
-5
JCI
50
-2
GOOGL
50
-4
NEM
49
-3
SIG
41
-3
ADT
45
-3
EXPE
77
-3
IR
60
-3
UA
42
4
WM
70
2
KLAC
42
2
APH
64
3
ISRG
74
-2
QRVO
34
-2
PWR
60
-6
EFX
38
-2
ES
63
5
PSA
48
2
KSS
49
-6
BAX
45
-2
MMM
30
-5
JCI
50
-2
GOOGL
50
-4
NEM
49
-3
SIG
41
-3
ADT
45
-3
EXPE
77
-3
IR
60
-3
UA
42
4
Financhill
Back

Fate Therapeutics Stock Price Chart

Escape the market madness with 7 stocks to buy and hold

Get the complete list FREE for a limited time.
Sell
34

FATE
Fate Therapeutics

Last Price:
2.81
Seasonality Move:
31.52%

7 Day Trial

ALL ACCESS PASS

$ 7

Don't put a penny in AI stocks until you read this

Discover this under-the-radar AI stock now, ahead of the crowd.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FATE is experiencing selling pressure, which indicates risk of future bearish movement.

Fate Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 3.13 Sell
20-day SMA: 3.2 Sell
50-day SMA: 3.48 Sell
200-day SMA: 4.69 Sell
8-day EMA: 3.13 Sell
20-day EMA: 3.23 Sell
50-day EMA: 3.48 Sell
200-day EMA: 4.29 Sell

Fate Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 39.11 Sell
Chaikin Money Flow: -751726 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.03 - 3.61) Sell
Bollinger Bands (100): (3.13 - 4.31) Sell

Fate Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Fate Therapeutics Stock

Is Fate Therapeutics Stock a Buy?

  • Fate Therapeutics share price is 3.03 while FATE 8-day simple moving average is 3.13, which is a Sell signal.
  • The stock price of FATE is 3.03 while Fate Therapeutics 20-day SMA is 3.20, which makes it a Sell.
  • Fate Therapeutics 50-day simple moving average is 3.48 while FATE share price is 3.03, making it a Sell technically.
  • FATE stock price is 3.03 and Fate Therapeutics 200-day simple moving average is 4.69, creating a Sell signal.

FATE Technical Analysis vs Fundamental Analysis

Sell
34
Fate Therapeutics (FATE) is a Sell

Is Fate Therapeutics a Buy or a Sell?

  • Fate Therapeutics stock is rated a Sell
    The current Fate Therapeutics [FATE] share price is $3.03. The Score for FATE is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.

Fate Therapeutics Stock Info

Market Cap:
345.05M
Price in USD:
3.03
Share Volume:
1.05M

Fate Therapeutics 52-Week Range

52-Week High:
8.83
52-Week Low:
1.63
Sell
34
Fate Therapeutics (FATE) is a Sell

Fate Therapeutics Share Price Forecast

Is Fate Therapeutics Stock a Buy?

  • Fate Therapeutics share price is 3.03 while FATE 8-day exponential moving average is 3.13, which is a Sell signal.
  • The stock price of FATE is 3.03 while Fate Therapeutics 20-day EMA is 3.23, which makes it a Sell.
  • Fate Therapeutics 50-day exponential moving average is 3.48 while FATE share price is 3.03, making it a Sell technically.
  • FATE stock price is 3.03 and Fate Therapeutics 200-day simple moving average is 4.29, creating a Sell signal.

Fundamental Analysis of Fate Therapeutics

Is Fate Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.03 per share.

Technical Analysis of Fate Therapeutics

Should I short Fate Therapeutics stock?

* Fate Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.